With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

Boston Scientific (NYSE:BSX) announced a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems due ...

Marlborough, Mass.-based Boston Scientific has launched Endura Weight Loss Solutions, a new category name for its minimally invasive endobariatric procedures such as endoscopic sleeve gastroplasty and ...

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ...

Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...

Boston Scientific recently reported fourth-quarter 2025 sales of US$5,286 million and net income of US$672 million, alongside 2026 guidance calling for double‑digit reported and organic net sales ...